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Definition
• Respiratory failure is a clinical syndrome in which the respiratory 
system fails in oxygenation (hypoxemia) or/and carbon dioxide 
(hypercapnia) elimination  due to dysfunction of one or more 
essential components (chest wall (including pleura and diaphragm), 
airways, alveolar, alveolar – capillary units, pulmonary circulation, 
nerves, central nervous system (CNS) or brain stem) of the respiratory 
system 
• Hypoxemic respiratory failure (type I) is characterized by an arterial 
oxygen tension (PaO2) lower than 60 mm Hg with a normal or low 
arterial carbon dioxide tension (PaCO2)  
• Hypercapnic respiratory failure (type II) is characterized by a 
PaCO2 higher than 50 mm Hg.  
http://emedicine.medscape.com/article/167981-overview en.wikipedia.org/wiki/Respiratory_failure
Epidemiology
• Incidence: about 360,000 cases per year in the United States
• 36% die during hospitalization
• Morbidity and mortality rates increase with age and presence of 
comorbidities and presence of comorbidities.
https ://www.thoracic.org/professionals/clinical-resources/critical-care/clinical-education/mechanical-ventilation/respiratory-failure-mechanical-ventilation.pdf
Risk Factors and Etiology
http://emedicine.medscape.com/article/167981-overview#a5
• Respiratory failure can be grouped according to the primary 
abnormality and the individual components of the respiratory system 
(e.g., CNS, peripheral nervous system, respiratory muscles, chest wall, 
airways, and alveoli).
• A variety of pharmacologic, structural, and metabolic disorders of the 
CNS are characterized by depression of the neural drive to breathe 
• Disorders of the peripheral nervous system, respiratory muscles, and 
chest wall lead to an inability to maintain a level of minute ventilation 
appropriate for the rate of carbon dioxide production 
• Severe airway obstruction is a common cause of acute and chronic 
hypercapnia 
• Diseases of the alveoli are characterized by diffuse alveolar filling, 
frequently resulting in hypoxemic respiratory failure, although 
hypercapnia may complicate the clinical picture.  
Risk Factors and Etiology 
Type I   
• Chronic obstructive pulmonary 
disease (COPD)
• Pneumonia
• Pulmonary edema
• Pulmonary fibrosis
• Asthma
• Pneumothorax
• Pulmonary embolism
• Pulmonary arterial 
hypertension
• Pneumoconiosis
• Granulomatous lung diseases
• Cyanotic congenital heart 
disease
• Bronchiectasis
• Acute respiratory distress 
syndrome (ARDS)
• Fat embolism syndrome
• Kyphoscoliosis
• Obesity
http://emedicine.medscape.com/article/167981-overview#a5
Risk Factors and Etiology 
Type II   
• COPD
• Severe asthma
• Drug overdose
• Poisonings
• Myasthenia gravis
• Polyneuropathy
• Poliomyelitis
• Primary muscle disorders
• Porphyria
• Cervical cordotomy
• Head and cervical cord injury
• Primary alveolar 
hypoventilation
• Obesity-hypoventilation 
syndrome
• Pulmonary edema
• ARDS
• Myxedema
• Tetanus
http://emedicine.medscape.com/article/167981-overview#a5
Risk Factors and Etiology
Respiratory failure in elderly patients.
https://www.researchgate.net/publication/10770800_Respiratory_failure_in_elderly_patients
Mechanism
• Respiratory failure may result from either a reduction in ventilatory 
capacity or an increase in ventilatory demand (or both)
• Ventilatory capacity can be decreased by a disease process involving 
any of the functional components of the respiratory system and its 
controller
• Ventilatory demand is augmented by an increase in minute 
ventilation and/or an increase in the work of breathing.
http://emedicine.medscape.com/article/167981-overview#a4
Mechanism                                           
Hypoxemic (type I) respiratory failure
• The mechanisms are ventilation-to-perfusion ratio (V/Q) mismatch 
and shunt  
• The low-V/Q units contribute to hypoxemia and hypercapnia and may 
occur either from a decrease in ventilation secondary to airway or 
interstitial lung disease or from overperfusion in the presence of 
normal ventilation; hypoxemia increases minute ventilation by 
chemoreceptor stimulation, but the PaCO2 generally is not affected 
• Shunt is defined as the persistence of hypoxemia despite 100% 
oxygen inhalation; the deoxygenated blood (mixed venous blood) 
bypasses the ventilated alveoli and mixes with oxygenated blood that 
has flowed through the ventilated alveoli, consequently leading to a 
reduction in arterial blood content ; shunt as a cause of hypoxemia is 
observed primarily in pneumonia, atelectasis, and severe pulmonary 
edema of either cardiac or noncardiac origin. 
http://emedicine.medscape.com/article/167981-overview#a4
Mechanism                                           
Hypercapnic (type II) respiratory failure
• At a constant rate of carbon dioxide production, PaCO2 is determined 
by the level of alveolar ventilation 
• The relation between PaCO2 and alveolar ventilation is hyperbolic
• As ventilation decreases below 4-6 L/min, PaCO2 rises precipitously
• A reduction in minute ventilation is observed primarily in the setting 
of neuromuscular disorders and CNS depression 
• Hypoventilation is an uncommon cause of respiratory failure and 
usually occurs from depression of the CNS from drugs or 
neuromuscular diseases affecting respiratory muscles 
Hypoventilation is characterized by hypercapnia and hypoxemia 
http://emedicine.medscape.com/article/167981-overview#a4
https://www.thoracic.org/professionals/clinical-resources/critical-care/clinical-education/mechanical-ventilation/respiratory-failure-mechanical-ventilation.pdf
• Type I
• Alveolar unit failure: collapse , flooding (edema, blood, pus, 
aspiration), fibrosis 
• Pulmonary vasculature failure): pulmonary embolism, pulmonary 
hypertension  
• Type II 
• Nervous system failure: central hypoventilation, neuropathies 
• Muscle (pump) failure: muscular dystrophies, myopathies
• Neuromuscular transmission failure: myasthenia gravis m
• Airway failure: obstruction, dysfunction
• Chest wall and pleural space failure: kyphoscoliosis, morbid 
obesity, pneumothorax , hydrothorax, hemothorax. 
Mechanism                                           
Etiologic Categories 
Classification 
International Classification of Diseases  
http://apps.who.int/classifications/icd10/browse/2016/en#/J45
• X Diseases of the respiratory system
• J95-J99 Other diseases of the respiratory system 
• J96 Respiratory failure, not elsewhere classified
• J96.0 Acute respiratory failure
• J96.1 Chronic respiratory failure
• J96.9 Respiratory failure, unspecified
Classification 
Types
http://www.webmd.com/asthma/tc/classification-of-asthma-topic-overview
• Type I or hypoxemic 
• Type II or hypercapnic
• Type III or perioperative  
• Type IV in patients who are intubated and ventilated in the process of 
resuscitation for shock
Classification 
Terms
http://www.webmd.com/asthma/tc/classification-of-asthma-topic-overview
• Acute
• Chronic
• Acute on chronic (e.g.  acute exacerbation of advanced COPD)
Symptoms and Signs
Chronic
• Difficulty breathing or shortness 
of breath, especially when active
• Coughing up mucous
• Wheezing
• Bluish tint to the skin, lips, or 
fingernails
• Rapid breathing
• Fatigue
• Anxiety
• Confusion
Acute
• An inability to breathe
• Bluish coloration in the skin, 
fingertips, or lips
• Restlessness
• Anxiety
• Confusion
• Altered consciousness
• Rapid, shallow breathing
• Racing heart
• Profuse sweating
http://www.healthline.com/health/chronic-respiratory-failure#Symptoms2healthline.com/health/acute-respiratory-failure#Symptoms5
History
• The diagnosis of acute or chronic respiratory failure begins with 
clinical suspicion of its presence
• Confirmation of the diagnosis is based on arterial blood gas analysis 
• Evaluation of an underlying cause must be initiated early, frequently 
in the presence of concurrent treatment for acute respiratory failure
• Cardiogenic pulmonary edema usually develops in the context of a 
history of left ventricular dysfunction or valvular heart disease
• Noncardiogenic edema (e.g., acute respiratory distress syndrome 
[ARDS]) occurs in typical clinical contexts, such as sepsis, trauma, 
aspiration, pneumonia, pancreatitis, drug toxicity, and multiple 
transfusions).
http://emedicine.medscape.com/article/167981-clinical
Physical Examination 1
• Localized pulmonary findings reflecting the acute cause of hypoxemia 
(e.g., pneumonia, pulmonary edema, asthma, or COPD), may be 
readily apparent
• In patients with ARDS, the manifestations may be remote from the 
thorax, such as abdominal pain or long-bone fracture
• Neurologic manifestations include restlessness, anxiety, confusion, 
seizures, or coma.
• Asterixis may be observed with severe hypercapnia
• Tachycardia and arrhythmias may result from hypoxemia and acidosis 
• Cyanosis, a bluish color of skin and mucous membranes, indicates 
hypoxemia 
• Dyspnea, an uncomfortable sensation of breathing, often 
accompanies respiratory failure 
http://emedicine.medscape.com/article/167981-clinical#b2
Physical Examination 2
• Excessive respiratory effort, vagal receptors, and chemical stimuli 
(hypoxemia and/or hypercapnia) all may contribute to the sensation 
of dyspnea 
• Both confusion and somnolence may occur in respiratory failure
• Myoclonus and seizures may occur with severe hypoxemia
• Polycythemia is a complication of long-standing hypoxemia
• Pulmonary hypertension is present in chronic respiratory failure
• Alveolar hypoxemia potentiated by hypercapnia causes pulmonary 
arteriolar constriction; if chronic, this is accompanied by hypertrophy 
and hyperplasia of the affected smooth muscles and narrowing of the 
pulmonary arterial bed
• The increased pulmonary vascular resistance increases afterload of 
the right ventricle, which may induce right ventricular failure (cor 
pulmonale).
http://emedicine.medscape.com/article/167981-clinical#b2
Complications
http://emedicine.medscape.com/article/167981-clinical#b3
• Pulmonary complications include pulmonary embolism, nosocomial 
pneumonia, barotrauma, pulmonary fibrosis, and complications 
secondary to the use of mechanical devices 
• Cardiovascular complications include hypotension, reduced cardiac 
output, arrhythmia, endocarditis, and acute myocardial infarction 
• Gastrointestinal complications are hemorrhage, gastric distention, 
stress ulceration, ileus, diarrhea, and pneumoperitoneum  
• Nosocomial infections (pneumonia, urinary tract infections, and 
catheter-related sepsis)  occur with the use of mechanical devices 
• Renal failure is the result of renal hypoperfusion and the use of 
nephrotoxic drugs 
• Nutritional complications are related to administration of enteral or 
parenteral nutrition.
Diagnosis 1
• Arterial blood gas analysis: confirmation of the diagnosis 
• Chest X-ray: often identifies the cause of respiratory failure 
• Complete blood count (CBC): anaemia can contribute to tissue 
hypoxia; polycythemia may indicate chronic hypoxemic respiratory 
failure 
• Renal function tests and liver function tests: may provide clues to the 
etiology or identify complications associated with respiratory failure  
• Serum creatine kinase and troponin I: to help exclude recent 
myocardial infarction 
• Thyroid function tests (TFTs): hypothyroidism may cause chronic 
hypercapnic respiratory failure 
• Spirometry: the evaluation of chronic respiratory failure. 
http://patient.info/doctor/respiratory-failure
Diagnosis 2
• Echocardiography: if a cardiac cause of acute respiratory failure is 
suspected 
• Pulmonary function tests: the evaluation of chronic respiratory failure 
• Electrocardiography (ECG): to evaluate a cardiovascular cause; it may 
also detect dysrhythmias resulting from severe hypoxemia or acidosis 
• Right heart catheterization: should be considered if there is 
uncertainty about cardiac function, adequacy of volume replacement 
and systemic oxygen delivery 
• Pulmonary capillary wedge pressure may be helpful in distinguishing 
cardiogenic from non-cardiogenic edema.
http://patient.info/doctor/respiratory-failure
Diagnosis 3
Acute Pulmonary Edema, Respiratory Failure, and LBBB: There is sinus 
tach with left bundle branch block (LBBB). There is excessively 
discordant ST elevation in leads V1 and V2. The highest ST/S ratio is in 
V1, with a ratio of 8/30 = 0.27, highly suggestive of LAD occlusion.
https://www.researchgate.net/publication/10770800_Respiratory_failure_in_elderly_patients
Diagnosis 4                                            
Hypoxic Respiratory Failure Criteria
• Hypoxic respiratory failure is diagnosed in patients without chronic 
lung disease when there is falling pulse oximetry from 92% saturation 
or initial pulse oximetry <80% saturation on room air (severe 
respiratory failure is diagnosed when arterial blood gas shows PaO2 
of <60 mmHg on room air)
• Patients with chronic lung disease may have low pulse oximetry 
readings and baseline PaO2 values of 50 mmHg, making worsening 
hypoxia difficult to recognise.
• Decreases of 10% from baseline oxygenation can indicate impending 
respiratory failure in patients with chronic lung disease. 
http://bestpractice.bmj.com/best-practice/monograph/853/diagnosis/criteria.html
Diagnosis 5                                         
Hypercapnic Respiratory Failure Criteria
• Hypercapnic respiratory failure is diagnosed in patients without 
chronic lung disease when there is hypoxia and acute elevation of 
arterial PaCO2 >45 to 50 mmHg and associated acidosis (pH <7.35)
• Patients with chronic lung disease can usually tolerate PaCO2 levels 
of up to 80 mmHg with secondary renal compensation
• Increasing acidosis (decreasing pH) in these patients indicates 
respiratory failure.
http://bestpractice.bmj.com/best-practice/monograph/853/diagnosis/criteria.html
Management 1
• The first objective in the management of respiratory failure is to 
reverse and/or prevent tissue hypoxia
• Hypercapnia unaccompanied by hypoxemia generally is well tolerated 
and probably is not a threat to organ function unless accompanied by 
severe acidosis when the arterial blood pH falls below 7.2
• Appropriate management of the underlying disease obviously is an 
important component in the management of respiratory failure 
• A patient with acute respiratory failure generally should be admitted 
to a respiratory care unit or intensive care unit (ICU)
• Most patients with chronic respiratory failure can be treated at home 
with oxygen supplementation and/or ventilatory assist devices along 
with therapy for their underlying disease 
http://emedicine.medscape.com/article/167981-treatment#d9
Management 2
Noninvasive ventilation in immunocompromised patients with acute 
respiratory failure.
https://www.hamilton-medical.com/de/Products/Mechanical-ventilators/HAMILTON-C3.html
Management 3
• Extracorporeal membrane oxygenation (ECMO) may be more effective 
than conventional management for patients with severe but 
potentially reversible respiratory failure 
• Assurance of an adequate airway with endotracheal intubation and 
ventilation are required in cases of severe respiratory failure (PaO2 
less than 50 mmHg);  another indication is airway protection in 
patients with altered mental status 
• Once the airway is secured, attention is turned toward correcting the 
underlying hypoxemia, the most life-threatening facet of acute 
respiratory failure
http://emedicine.medscape.com/article/167981-treatment#d9
Management 4
• The goal is to assure adequate oxygen delivery to tissues, generally 
achieved with an arterial oxygen tension (PaO2) of 60 mm Hg or an 
arterial oxygen saturation (SaO2) greater than 90%
• Respiratory stimulants such as doxapram are rarely used, and if the 
respiratory failure resulted from an overdose of sedative drugs such 
as opioids or benzodiazepines, then the appropriate antidote
(naloxone or flumazenil, respectively) will be given 
• There is tentative evidence that in those with respiratory failure 
identified before arrival in hospital, continuous positive airway 
pressure can be useful when started before conveying to hospital.
https://en.wikipedia.org/wiki/Respiratory_failure
Management 5
A nasal cannula and portable oxygen container are attached to 
a patient.
https://www.hamilton-medical.com/de/Products/Mechanical-ventilators/HAMILTON-C3.html
Prognosis
• The mortality varies according to the etiology
• For ARDS, mortality is up to 45%  
• Significant mortality occurs in patients admitted with hypercapnic 
respiratory failure 
• For patients with COPD and acute respiratory failure, the overall 
mortality is up to 26%.
http://emedicine.medscape.com/article/167981-overview#a7
Prophylaxis
• Prevention is based on risk awareness of relevant medical conditions 
or trauma, and control or correction of underlying illnesses or injuries
• It is standard practice to administer influenza and pneumococcal 
vaccinations to patients at risk of respiratory failure with the thought 
that the vaccines control influenza and pneumococcal pneumonia 
and can help prevent respiratory failure in vulnerable groups 
• Smoking cessation for all patients with lung disease limits the 
progression of pulmonary dysfunction  
• Monitoring and continued medical management of patients with 
relevant chronic lung disease helps limit acute exacerbations and 
reduces the risk of respiratory failure.
•
https ://online.epocrates.com/diseases/85344/Acute-respiratory-failure/Prevention
Abbreviations 
ARDS - acute respiratory distress syndrome
CBC - complete blood count
CNS - central nervous system
COPD - chronic obstructive pulmonary disease
ECG - electrocardiography
ECMO - Extracorporeal membrane oxygenation 
ICU - intensive care unit 
TFTs - thyroid function tests
V/Q - ventilation-to-perfusion ratio 
Diagnostic and treatment guidelines
BTS/ICS guideline for the ventilatory management of 
acute hypercapnic respiratory failure in adults
Respiratory Failure
Respiratory Failure
Respiratory Failure Treatment & Management
Treatment of respiratory failure in COPD
